Endocrine Drugs - Diabetes Flashcards

1
Q

peptide hormone secreted by alpha cells in langerhan

A

glucagon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

peptide hormone secreted by betacells in langerhan

A

insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

peptide hormone secreted by delta cells in langerhan

A

somatostatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

storage form of insulin

A

hexamer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

active form of insulin

A

monomer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

based on therapeutic use: short acting

A

prandial insulin
control post-prandial hyperglycemia (when you eat meals)

insulin (based on use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

based on therapeutic use: long acting

A

basal insulin
control blood level throughout the day

insulin (based on use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

insulin lispro

A

Humalog
ultra-rapid/short acting (30 mins)
given right before or after meal

insulin (based on duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

insulin aspart

A

Novolog
ultra-rapid/short acting (30 mins)
given right before or after meal

insulin (based on duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

insulin glulisine

A

Apidra
given right before or after meal

ultra-rapid/short acting (30 mins)
insulin (based on duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

regular insulin

A

only insulin given via IV
given 30 mins before meal
mgx of hyperkalemia

short acting
insulin (based on duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

isophane insulin

A

neutral protamine hagedorn (NPH)
given twice a day (half life= 10-18 hrs)

intermediate acting
insulin (based on duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

insulin glargine

A

given once a day (half life: 18-20 hrs)

long acting
insulin (based on duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

insulin detemir

A

given once a day (half life: 18-20 hrs)
shorted durationg among long

long acting
insulin (based on duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

insulin degludec

A

given once a day (half life: 18-20 hrs)
longest duration

long acting
insulin (based on duration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

chlorpropamide

A

longest half life, most s/e

s/e: weight gain
1st gen sulfonylurea (not used anmr)
insulin secretagogues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

tolbutamide

A

fastest onset, most cardiotoxic

s/e: weight gain
1st gen sulfonylurea (not used anmr)
insulin secretagogues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

acetohexamide

A

active: hydrohexamide

s/e: weight gain
1st gen sulfonylurea (not used anmr)
insulin secretagogues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

tolazamide

A

s/e: weight gain
1st gen sulfonylurea (not used anmr)
insulin secretagogues

20
Q

glibenclamide

A

s/e: weight gain
2ng gen sulfonylurea (more potent)
insulin secretagogues

21
Q

glipizide

A

s/e: weight gain
2ng gen sulfonylurea (more potent)
insulin secretagogues

22
Q

gliclazide

A

s/e: weight gain
2ng gen sulfonylurea (more potent)
insulin secretagogues

23
Q

glimepiride

A

s/e: weight gain
2ng gen sulfonylurea (more potent)
insulin secretagogues

24
Q

repaglinide

A

control of post-prandial hyperglycemia
for px allergic to sulfonylureas

s/e: weight gain
meglitinides
insulin secretagogues

25
Q

nateglinide

A

control of post-prandial hyperglycemia
for px allergic to sulfonylureas

s/e: weight gain
meglitinides
insulin secretagogues

26
Q

phenformin

A

withdrawn for the market

dec hepatic glucose production
inc peripheral response to insulin

biguanide

27
Q

metformin

A

first line for type II DM
only drug for pre-diabetes
s/e: weight gain, risk of lactic acidosis

dec hepatic glucose production
inc peripheral response to insulin

biguanide

28
Q

acarbose

A

adr: flatulentce
CI: IBD

a-glucosidade = converts sugar to glucose

alpha-glucosidase inh

29
Q

miglitol

A

adr: flatulentce
CI: IBD

a-glucosidade = converts sugar to glucose

alpha-glucosidase inh

30
Q

pioglitazone

A

acts on PPAR gamma
inc insulin sensitivity

adr: bladder cancer
weight gain, edema = CHF

thiazolidinediones

31
Q

rosiglitazone

A

acts on PPAR gamma
inc insulin sensitivity

adr: cardiovascular
weight gain, edema = CHF

thiazolidinediones

32
Q

amylin

A

dec glucagon secretion
inc peripheral response
s/e: weight loss

amylin analogue

33
Q

pramlintide

A

dec glucagon secretion
inc peripheral response
s/e: weight loss

amylin analogue

34
Q

exenatide

A

activates glucagon-like peptide-1 = stimulates insulin release (incretin)

given SQ
s/e: weight loss

GLP1 agonist
incretin analogue

35
Q

liraglutide

A

given SQ
s/e: weight loss

GLP1 agonist
incretin analogue

36
Q

saxagliptin

A

orally
comes 2nd to metformin

dipeptidyl peptidase IV = degrades GLP1

DPP-4 inhibitor

37
Q

vildagliptin

A

orally
comes 2nd to metformin

dipeptidyl peptidase IV = degrades GLP1

DPP-4 inhibitor

38
Q

linagliptin

A

safe for renal; used in dialysis px
orally
comes 2nd to metformin

dipeptidyl peptidase IV = degrades GLP1

DPP-4 inhibitor

39
Q

dapagliflozin

A

sodium-glucose transport 2 = reabsorbs filtered glucose

s/e: UTI, weight loss

inc urinary glucose secretion
SGLT-2 inhibitor

40
Q

cut off blood sugar to dx hypoglycemia

A

70

41
Q

blood glucose monitoring

A

capillary blood glucose (CBG)

42
Q

check sugar control (glucose level for past 3 months)

A

HBA1c

43
Q

1st line for type II dm

A

metformin

44
Q

1st line for type I dm

A

insulin

45
Q

post prandial

A

alpha 1-4 amy

a glucosidase inh
glp-1 agonist
DPPP-4 inh
amylin analogues

46
Q

weight loss

A

1,2 amy

glp-1 agonist
sglt-2 inh
amylin analogues
metformin